Lannett Company Inc (LCI)

LCI on New York Consolidated

24.82USD
5 Feb 2016
Change (% chg)

$-1.91 (-7.15%)
Prev Close
$26.73
Open
$26.35
Day's High
$26.43
Day's Low
$23.32
Volume
2,887,533
Avg. Vol
1,146,485
52-wk High
$72.44
52-wk Low
$22.75

LCI

Chart for LCI

About

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company's products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $904.87
Shares Outstanding(Mil.): 36.46
Dividend: --
Yield (%): --

Financials

  LCI Industry Sector
P/E (TTM): 7.93 31.76 38.72
EPS (TTM): 3.13 -- --
ROI: 11.78 15.12 14.47
ROE: 25.17 15.85 15.40
Search Stocks

Lannett to buy UCB unit to boost specialty generic drugs portfolio

Lannett Co Inc said it would buy Kremers Urban Pharmaceuticals Inc, a U.S. unit of Belgian drugmaker UCB SA , for $1.23 billion to expand its specialty generic drugs portfolio.

02 Sep 2015

UPDATE 2-Lannett to buy UCB unit to boost specialty generic drugs portfolio

* Lannett shares rise about 17 pct after market (Adds details from conference call; updates shares)

02 Sep 2015

Drugmaker Lannett to buy UCB unit Kremers Urban for $1.23 bln

Sept 2 Drugmaker Lannett Co Inc said it would buy specialty generic drug maker Kremers Urban Pharmaceuticals Inc for $1.23 billion to expand its product portfolio.

02 Sep 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks